RxDoctor Payments Data

Christopher Selgrath, DO

Adult Reconstructive Orthopaedic Surgery · Philadelphia, PANPI 1801990361

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $912 of the $1,145 with a category attached, or 79.6%. 15 manufacturers reported payments, led by Stryker at 40.4% of the total. Reporting peaked in 2024 at $285 and has fallen 88.7% since, to $32 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in PA, where the typical reported total is $4,565.

$1,145in general payments, 2019–2025

Across 29 payments — averaging $39.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$462
  • Zimmer Biomet$336
  • Heraeus Medical, LLC.$83
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$73
  • Vertex$32
  • Johnson & Johnson$23
  • plus $137 from 9 others

What the payments were for

  • Food & beverage$91280%
  • Education$23420%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,145 in reported general payments places this provider in the 25th percentile of 51 adult reconstructive orthopaedic surgery providers in Pennsylvania.

See all adult reconstructive orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$186,147
Medicare patients
314
Services billed
6,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam408$2,196
Methylprednisolone194$1,636
Celecoxib12$513
Diclofenac Sodium39$449
Naproxen21$382
Tramadol Hcl76$273
Ibuprofen29$262
Pregabalin29$202
Ondansetron OdtOndansetron24$192
Oxycodone Hcl40$98

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →